The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hypoxia-inducible factor (HIF) 1α and 2α as predictive markers of outcome to VEGFR tyrosine kinase inhibitors (TKI) in renal cell carcinoma (RCC).
M.I. Saez
No relevant relationships to disclose
Jose Manuel Trigo Perez
No relevant relationships to disclose
L.G. Perez-Rivas
No relevant relationships to disclose
L. Perez-Villa
No relevant relationships to disclose
R. Villatoro
No relevant relationships to disclose
A. Montesa
No relevant relationships to disclose
J.I. Cid
No relevant relationships to disclose
M. Leon
No relevant relationships to disclose
V. de Luque
No relevant relationships to disclose
C. Fernandez
No relevant relationships to disclose
C. Quero
No relevant relationships to disclose
B. Pajares
No relevant relationships to disclose
E. Alba
No relevant relationships to disclose